Collagen VII plays a dual role in wound healing

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3498-3509

  Nyström, Alexander ^a   Velati, Daniela ^a   Mittapalli, Venugopal R ^a   Fritsch, Anja ^a   Kern, Johannes S ^a   Bruckner Tuderman, Leena ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COL7A1 PROTEIN; COLLAGEN TYPE 7; KALININ; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITHELIZATION; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN FRAGILITY; WOUND CLOSURE; WOUND HEALING;

ANIMALS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLASTS; GRANULATION TISSUE; HUMANS; INTEGRIN ALPHA6BETA4; KERATINOCYTES; MICE; MICE, TRANSGENIC; RE-EPITHELIALIZATION; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 84880560978     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI68127     Document Type: Article

References (56)

1. Coulombe PA. Wound epithelialization: accelerating the pace of discovery. J Invest Dermatol. 2003; 121(2):219-230.
2. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341(10):738-746.
3. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008;9(8):628-638.
4. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003; 83(3):835-870.
5. Ko MS, Marinkovich MP. Role of dermal-epidermal basement membrane zone in skin, cancer, and developmental disorders. Dermatol Clin. 2010; 28(1):1-16.
6. Bruckner-Tuderman L, Höpfner B, Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol. 1999; 18(1):43-54.
7. Bruckner-Tuderman L. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: Epidermolysis bullosa. Eur J Dermatol. 2008;18(2):214-216.
8. Tsuruta D, Hashimoto T, Hamill KJ, Jones JC. Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing. J Dermatol Sci. 2011;62(1):1-7.
9. Sehgal BU, et al. Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J Biol Chem. 2006;281(46):35487-35498.
10. Pullar CE, et al. beta4 integrin and epidermal growth factor coordinately regulate electric fieldmediated directional migration via Rac1. Mol Biol Cell. 2006;17(11):4925-4935.
11. Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol. 1998;141(1):255-265.
12. Kligys K, et al. The slingshot family of phosphatases mediates Rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility behavior of keratinocytes. J Biol Chem. 2007; 282(44):32520-32528.
13. Sakai LY, Keene DR, Morris NP, Burgeson RE. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986;103(4):1577-1586.
14. Van Agtmael T, Bruckner-Tuderman L. Basement membranes and human disease. Cell Tissue Res. 2010;339(1):167-188.
15. Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol. 2012;30(1):70-77.
16. Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2007;44(3):181-192.
17. Bruckner-Tuderman L. Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin. 2010;28(1):107-114.
18. Fine JD, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008; 58(6):931-950.
19. Tolar J, Blazar BR, Wagner JE. Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa. Stem Cells. 2011;29(6):900-906.
20. Woodley DT, et al. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther. 2007;15(3):628-635.
21. Conget P, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12(3):429-431.
22. Fritsch A, et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest. 2008;118(5):1669-1679.
23. Guo W, et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell. 2006;126(3):489-502.
24. Nikolopoulos SN, et al. Targeted deletion of the integrin beta4 signaling domain suppresses laminin- 5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol. 2005;25(14):6090-6102.
25. Waterman EA, et al. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res. 2007;67(9):4264-4270.
26. Iyer VR, et al. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283(5398):83-87.
27. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816-827.
28. Woodley DT, Hou Y, Martin S, Li W, Chen M. Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis. J Biol Chem. 2008;283(26):17838-17845.
29. Martins VL, et al. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci. 2009;122(pt 11):1788-1799.
30. Frank DE, Carter WG. Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci. 2004;117(pt 8):1351-1363.
31. Zhang Z, et al. Migration of epithelial cells on laminins: RhoA antagonizes directionally persistent migration. Eur J Cell Biol. 2011;90(1):1-12.
32. Sullivan SR, et al. Topical application of laminin- 332 to diabetic mouse wounds. J Dermatol Sci. 2007;48(3):177-188.
33. Margadant C, Raymond K, Kreft M, Sachs N, Janssen H, Sonnenberg A. Integrin alpha3beta1 inhibits directional migration and wound re-epithelialization in the skin. J Cell Sci. 2009;122(pt 2):278-288.
34. O'Toole EA, Marinkovich MP, Hoeffler WK, Furthmayr H, Woodley DT. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res. 1997; 233(2):330-339.
35. Kariya Y, Sato H, Katou N, Kariya Y, Miyazaki K. Polymerized laminin-332 matrix supports rapid and tight adhesion of keratinocytes, suppressing cell migration. PLoS One. 2012;7(5):e35546.
36. Raymond K, Kreft M, Janssen H, Calafat J, Sonnenberg A. Keratinocytes display normal proliferation, survival and differentiation in conditional beta4-integrin knockout mice. J Cell Sci. 2005; 118(pt 5):1045-1060.
37. Hintermann E, Bilban M, Sharabi A, Quaranta V. Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol. 2001;153(3):465-478.
38. Hintermann E, Yang N, O'Sullivan D, Higgins JM, Quaranta V. Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. J Biol Chem. 2005; 280(9):8004-8015.
39. Owens DM, Romero MR, Gardner C, Watt FM. Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling. J Cell Sci. 2003; 116(pt 18):3783-3791.
40. Chen M, O'Toole EA, Li YY, Woodley DT. Alpha 2 beta 1 integrin mediates dermal fibroblast attachment to type VII collagen via a 158-amino-acid segment of the NC1 domain. Exp Cell Res. 1999; 249(2):231-239.
41. Chen M, Costa FK, Lindvay CR, Han YP, Woodley DT. The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J Biol Chem. 2002;277(3):2118-2124.
42. Woodall BP, et al. Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity. J Biol Chem. 2008;283(4):2335-2343.
43. Ng YZ, et al. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res. 2012; 72(14):3522-3534.
44. Järvinen TA, Ruoslahti E. Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci U S A. 2010;107(50):21671-21676.
45. Han G, Wang XJ. Roles of TGFbeta signaling Smads in squamous cell carcinoma. Cell Biosci. 2011;1:41.
46. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech. 2010;43(1):146-155.
47. Wells RG, Discher DE. Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci Signal. 2008;1(10):pe13.
48. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007; 179(6):1311-1323.
49. Evans RA, Tian YC, Steadman R, Phillips AO. TGFbeta1- mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res. 2003;282(2):90-100.
50. Cowin AJ, et al. Flightless I deficiency enhances wound repair by increasing cell migration and proliferation. J Pathol. 2007;211(5):572-581.
51. Kopecki Z, et al. Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol. 2011;225(3):401-413.
52. Fritsch A, et al. Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII. J Biol Chem. 2009;284(44):30248-30256.
53. Kern JS, et al. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther. 2009;17(9):1605-1615.
54. Franzke CW, et al. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med. 2012;209(6):1105-1119.
55. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest. 1993;92(3):1425-1435.
56. Schéele S, Nyström A, Durbeej M, Talts JF, Ekblom M, Ekblom P. Laminin isoforms in development and disease. J Mol Med (Berl). 2007;85(8):825-836.